Concepedia

Phase II trial of arsenic trioxide in relapsed and refractory acute myeloid leukemia, secondary leukemia and/or newly diagnosed patients at least 65 years old

Simrit Parmar, Lynn M. Rundhaugen, Larry Boehlke, Mary Beth Riley, Chadi Nabhan, Adekunle Raji, John L. Frater, Martin S. Tallman

Leukemia Research · 2004 · 57 citations · 58 references

DOI

Concepts

References

58

Optimal two-stage designs for phase II clinical trials

Richard Simon · Controlled Clinical Trials · 1989 · 3.6K citations

, , +10

Proposed Revised Criteria for the Classification of Acute Myeloid Leukemia

John M. Bennett · Annals of Internal Medicine · 1985 · 3K citations

, , +8

Hematology: Basic Principles and Practice

Annals of Internal Medicine · 1991 · 1.9K citations

, , +17

Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia

Robert J. Mayer, Roger B. Davis, Charles A. Schiffer et al. · New England Journal of Medicine · 1994 · 1.4K citations · Full text

, , +13

Use of Arsenic Trioxide (As2O3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): II. Clinical Efficacy and Pharmacokinetics in Relapsed Patients

Zhixiang Shen, Guoqiang Chen, Jian-Hua Ni et al. · Blood · 1997 · 1.4K citations

, , +17